NCT01027065 - Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

November 30, 2012

Study Completion Date

March 31, 2013

Conditions

Chronic Hepatitis B

Interventions

DRUG

CYT107+GenHevac+entecavir or tenofovir

4 patients per arm for each dose level. 3 patients receiving experimental treatment (CYT107 and vaccine) in addition to current antiviral treatment and 1 control patient only the current antiviral treatment

DRUG

CYT107+ entecavir or tenofovir

4 patients per arm for each dose level. 3 patients receiving experimental treatment (CYT107) in addition to current antiviral treatment and 1 control patient only the current antiviral treatment

Trial Locations (8)

Unknown

Hopital Henri Mendor-Service d'HepatoGastroEnterologie, Créteil

Hopital Michallon, Grenoble

Hopital de l'Hotel Dieu, Lyon

Hopital Saint Joseph, Marseille

CHU l'Archet, Nice

Hopital Tenon, Paris

Hopital Civil, Strasbourg

Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola Malpighi, Bologna